Cherry Creek Investment Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Cherry Creek Investment Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Cherry Creek Investment Advisors from 13F filings

Historical chart of Cherry Creek Investment Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Cherry Creek Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Cherry Creek Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 13k 103.17

More positions owned by Cherry Creek Investment Advisors

Invesco Actively Managed Exc Var Rate Invt (VRIG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
First Tr Exchange Traded Nasd Tech Div (TDIV)
Apple (AAPL)
International Business Machines (IBM)
Wal-Mart Stores (WMT)
Palantir Technologies Cl A (PLTR)
First Tr Exchange-traded SHS (FVD)
Abbvie (ABBV)
Visa Com Cl A (V)
Mongodb Cl A (MDB)
Vertiv Holdings Com Cl A (VRT)
Pure Storage Cl A (PSTG)

View all positions for Cherry Creek Investment Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf